Facilitation of adenoviral wild-type p53-induced apoptotic cell death by overexpression of p33ING1 in T.Tn human esophageal carcinoma cells
- 14 February 2002
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 21 (8) , 1208-1216
- https://doi.org/10.1038/sj.onc.1205176
Abstract
To investigate the effect of p33ING1 on wild-type p53 gene therapy, T.Tn human esophageal carcinoma cells were stably transfected with p33ING1 cDNA. Infection with Ad-p53 (recombinant adenovirus containing wild-type p53) into p33-transfected cells reduced cell viability, while infection with empty vector had little effect. This reduced viability was shown to be due to apoptotic cell death by the TUNEL (terminal deoxynucleotidyl transferase-mediated nick end-labeling) assay. Following infection with Ad-p53, levels of p53 were similar in p33-expressing cells and in the parental line. However, levels of p21 and Mdm2 were elevated in p33-transfected cells. Nonetheless, this enhanced expression of Mdm2 appeared to be ineffective in downregulating p53. Transient transfection with mutant Mdm2 prior to Ad-p53 infection provided a significant protection as compared with cells transfected with wild-type Mdm2. These results imply a synergistic effect between p33 and p53 in the induction of apoptosis of human esophageal carcinoma cells. A role for Mdm2 in this synergism is suggested.Keywords
This publication has 59 references indexed in Scilit:
- Caspase-dependent apoptosis by ectopic expression of E2F-4Oncogene, 2000
- DNA-damaging Aryl Hydrocarbons Induce Mdm2 Expression via p53-independent Post-transcriptional MechanismsPublished by Elsevier ,2000
- Decreased expression of p33ING1 mRNA in lymphoid malignanciesAmerican Journal of Hematology, 1999
- Suppression of ING1 expression in sporadic breast cancerOncogene, 1999
- A role of cyclin G in the process of apoptosisOncogene, 1999
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- Cancer Cell CyclesScience, 1996
- Safety Evaluation of Ad5CMY-p53 In VitroandIn VivoHuman Gene Therapy, 1995
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993